Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Gastrointestinal Medicine
Volume 2018 (2018), Article ID 2139607, 3 pages
https://doi.org/10.1155/2018/2139607
Case Report

A Case of Acute Autoimmune Hepatitis Superimposed on Chronic Hepatitis B Infection

1Department of Internal Medicine, St. Joseph’s University Medical Center, Paterson, NJ, USA
2Department of Gastroenterology and Hepatology, St. Joseph’s University Medical Center, Paterson, NJ, USA

Correspondence should be addressed to Hiren G. Patel; moc.liamg@727nerih

Received 2 January 2018; Revised 18 February 2018; Accepted 28 February 2018; Published 1 April 2018

Academic Editor: Olga I. Giouleme

Copyright © 2018 Vanessa Sostre et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Shoenfeld, N. Agmon-Levin, and N. R. Rose, Infection and Autoimmunity, 2018, https://books.google.com/books?id=hwzU7K7U4OgC&pg=PA221&lpg=PA221&dq=Elsevier+Viral+Infection+and+Autoimmune+Hepatitis+-+Sandro+Vento+and+Francesca+Cainelli&source=bl&ots=pgjMZTIcm9&sig=c8YyeUxoxXDgf9VMY37M5aMeQnI&hl=en&sa=X&ved=0ahUKEwjs8cTo1dzXAhWhkOAKH.
  2. European Association for the Study of the Liver, “EASL clinical practice guidelines: autoimmune hepatitis,” Journal of Hepatology, vol. 63, no. 4, pp. 971–1004, 2015. View at Publisher · View at Google Scholar
  3. T. Laskus and J. Slusarczyk, “Autoimmune chronic active hepatitis developing after acute type B hepatitis,” Digestive Diseases and Sciences, vol. 34, no. 8, pp. 1294–1297, 1989. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Murakami, K. Hino, M. Okazaki et al., “Hepatitis B virus carrier status linked to autoimmune hepatitis,” Internal Medicine, vol. 35, no. 6, pp. 468–471, 1996. View at Publisher · View at Google Scholar
  5. H. Bécheur, D. Valla, M. A. Loriot, A. Attar, F. Bloch, and J. P. Petite, “Concurrent emergence of hepatitis B e antigen-negative hepatitis B virus variant and autoimmune hepatitis cured by adenine arabinoside monophosphate,” Digestive Diseases and Sciences, vol. 43, no. 11, pp. 2479–2482, 1998. View at Google Scholar
  6. A. J. Czaja, H. A. Carpenter, P. J. Santrach, S. Breanndan Moore, H. F. Taswell, and H. A. Homburger, “Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States,” Journal of Hepatology, vol. 18, no. 3, pp. 342–352, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Pawlowska and W. Halota, “Acute liver failure caused by concurrent autoimmune hepatitis and hepatitis B in a 16-year old girl,” World Journal of Hepatology, vol. 2, no. 10, pp. 392–394, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Maya, M. E. Gershwin, and Y. Shoenfeld, “Hepatitis B virus (HBV) and autoimmune disease,” Clinical Reviews in Allergy & Immunology, vol. 34, no. 1, pp. 85–102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. I. G. McFarlane, “Immunological abnormalities and hepatotropic viral infections,” Clinical & Experimental Immunology, vol. 87, no. 3, pp. 337–339, 1992. View at Publisher · View at Google Scholar
  10. Q. X. Wang, W. J. Jiang, Q. Miao et al., “Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients: A single center experience,” Journal of Digestive Diseases, vol. 14, no. 4, pp. 175–180, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Maggiore, G. Socie, M. Sciveres et al., “Seronegative autoimmune hepatitis in children: Spectrum of disorders,” Digestive and Liver Disease, vol. 48, no. 7, pp. 785–791, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Sherigar, A. Yavgeniy, D. Guss, N. Ngo, and S. Mohanty, “Seronegative autoimmune hepatitis a clinically challenging difficult diagnosis,” Case Reports in Medicine, vol. 2017, Article ID 3516234, pp. 1–3, 2017. View at Publisher · View at Google Scholar
  13. A. J. Czaja, J. E. Hay, and J. Rakela, “Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis,” Mayo Clinic Proceedings, vol. 65, no. 1, pp. 23–30, 1990. View at Publisher · View at Google Scholar · View at Scopus
  14. D. J. Gassert, H. Garcia, K. Tanaka, and J. F. Reinus, “Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis,” Digestive Diseases and Sciences, vol. 52, no. 9, pp. 2433–2437, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Heringlake, A. Schütte, P. Flemming, W. Schmiegel, M. P. Manns, and H. L. Tillmann, “Presumed cryptogenic liver disease in Germany: high prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology,” Zeitschrift für Gastroenterologie, vol. 47, no. 5, pp. 417–423, 2009. View at Publisher · View at Google Scholar · View at Scopus